FDA and CMS work to avoid conflict over state AI rules
US health regulators are quietly acting to prevent clashes with states testing artificial intelligence in clinical care.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
The FDA and CMS are moving behind the scenes to head off a brewing conflict between states and the federal government over regulating AI. More states are looking to test AI in clinical settings. Health officials are seeking to prevent conflicts between state and federal authorities over AI systems that perform clinical tasks.
Coverage
- FDA and CMS seek to avoid regulatory gridlock over medical AI (ua.news)
- FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings (statnews.com)
More from Technology & AI
- China puts humanoid robots to work serving food and sorting parcels
- Newsom proposes sweeping AI safety rules for Washington
- Google releases Gemini 4 Neon AI model with million-token context
- Microsoft and Intel widen their cloud chip partnership
- Google DeepMind rolls out Genie 4 to select subscribers
- AI helped AMD shorten chip design work, OpenAI says